Literature DB >> 10364766

Management of hemorrhagic events in patients receiving anticoagulant therapy.

D G Love1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364766     DOI: 10.1023/a:1008885504228

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  12 in total

Review 1.  The safety of blood components and derivatives.

Authors:  C Julius; R G Westphal
Journal:  Hematol Oncol Clin North Am       Date:  1992-10       Impact factor: 3.722

2.  Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect.

Authors:  F Fernandez; P N'guyen; J Van Ryn; F A Ofosu; J Hirsh; M R Buchanan
Journal:  Thromb Res       Date:  1986-08-15       Impact factor: 3.944

3.  Acute cardiovascular collapse during intravenous vitamin K1 injection.

Authors:  J J Lefrère; R Girot
Journal:  Thromb Haemost       Date:  1987-08-04       Impact factor: 5.249

Review 4.  New antithrombotics.

Authors:  J I Weitz; R M Califf; J S Ginsberg; J Hirsh; P Théroux
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

Review 5.  Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.

Authors:  M N Levine; S Z Goldhaber; J M Gore; J Hirsh; R M Califf
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

Review 6.  Hemorrhagic complications of anticoagulant treatment.

Authors:  M N Levine; G Raskob; S Landefeld; J Hirsh
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

Review 7.  Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller; H Bussey
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

8.  Severe complications of intravenous phytonadione therapy. Two cases, with one fatality.

Authors:  E C Rich; C W Drage
Journal:  Postgrad Med       Date:  1982-11       Impact factor: 3.840

9.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

Authors:  C S Landefeld; M W Rosenblatt; L Goldman
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

Review 10.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Authors:  C S Landefeld; R J Beyth
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

View more
  1 in total

1.  Acquired inhibitors: a special case of bleeding in older adults.

Authors:  Richard G Stefanacci
Journal:  Curr Gerontol Geriatr Res       Date:  2012-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.